FIRSTENERGY $38.25

up +0.10


18/6/2013 04:18 PM  |  NYSE : FE  |  Industries : Utilities / Electric Power Generation, Transmission and Distribution
Last Trade: 38.25
Trade Time: Jun 18 4:08 PM Eastern Daylight Time
Change: 0.10 (0.26 %)
Prev Close: 38.15
Open: 38.15
Bid: 38.17
Ask: 38.28
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get FE Trend Analysis - it has underperformed the S&P 500 by 45%

ETF Alternatives



People viewing FE also viewed: , , , ,

Competitors

Ticker Name Volume % Change
NEVE NEVO ENERGY 416.0 +3.00%
WTWO W2 ENERGY 784.7K +0.50%
MINE MINERCO RESOURCES 41.3M +0.33%
WNEA WIND ENERGY AMERICA 5.0K +0.16%
VELPP VIRGINIA ELECTRIC & POWER 100.0 +0.12%

Insider Transactions

Date Name Title Volume Trade Price Holding Change
5/10/2013 CARTWRIGHT CAROL A Director 714 $42.75 2.30%
5/10/2013 REIN CATHERIN A Director 714 $42.75 18.55%
3/19/2013 Pearson James F SVP & CFO -2,000 $41.58 -22.99%
3/19/2013 CAVALIER LYNNETTE M Senior VP, Human Resources -20,808 $41.48 -25.21%
3/19/2013 CAVALIER LYNNETTE M Senior VP, Human Resources -6,803 $41.60 -100.00%
Data provided by Insiderslab.com. To read detailed Insider Trading Research Report for (FE), click here.

FE Stock Analysis

  1. Ariad's Iclusig in GIST Phase II Study - Analyst Blog

    The study will evaluate Iclusig's efficacy and safety in patients who have failed at least one tyrosine kinase inhibitor therapy.
  2. LIFE Continues Korean Expansion - Analyst Blog

    Life Technologies recently acquired a South Korea-based distributor, Life Science Korea.
  3. Apremilast Data Presented by Celgene - Analyst Blog

    Celgene presented data from the PALACE 3 study on apremilast.
  4. Lilly Alzheimer's Study Terminated - Analyst Blog

    The phase II study was voluntarily terminated due to the identification of abnormal liver biochemical tests during routine monitoring.
  5. FE Steps Up Power Stability Program - Analyst Blog

    FirstEnergy moves forward with its vegetation management programs.
  6. $2.15B Settlement for Pfizer's Protonix - Analyst Blog

    While Teva will make a payment of $1.6 billion, Sun Pharma will pay the remaining $550 million.
Free Reports
  1. 7 Proven Strategies for Market-Stomping Stocks

    Discover Investing Strategies that will Benefit Every Investor Today!
  2. View the Portfolios of the Worlds Top Investors, FREE!

    Learn from Warren Buffett, George Soros and More!
  3. Free Managed Futures Book

    Get the four benefits of managed futures as outlined in this booklet.
Marketplace
Trading Center